Mycophenolate mofetil for Crohn's disease: short‐term efficacy and long‐term outcome

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2004.01856.xPMID 14871282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory bowel disease.

  2002cited by this paper
• Toxicity of Mycophenolate Mofetil in Patients with Inflammatory Bowel Disease

  2002cited by this paper
• Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?

  2001cited by this paper
• The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprine

  2001cited by this paper
• A randomized double‐blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

  2001cited by this paper
• Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

  2000cited by this paper
• Efficacy of Mycophenolate Mofetil in Patients Failing 6‐Mercaptopurine or Azathioprine Therapy for Crohn's Disease

  2000cited by this paper
• Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease.

  1999cited by this paper
• Mycophenolate mofetil in IBD patients.

  1999cited by this paper
• Induction of inosine monophosphate dehydrogenase activity after long‐term treatment with mycophenolate mofetil

  1999cited by this paper
• Successful treatment of erythrodermic psoriasis with mycophenolate mofetil.

  1998cited by this paper
• Mycophenolate mofetil in patients with Crohn's disease

  1998cited by this paper
• A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

  1998cited by this paper
• Successful treatment of erythrodermic psoriasis with mycophenolate mofetil

  1998cited by this paper
• Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease

  1998cited by this paper
• Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF)

  1998cited by this paper
• A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation.

  1998cited by this paper
• A Blinded, Long-term, Randomized Multicenter Study Of Mycophenolate Mofetil In Cadaveric Renal Transplantation: Results at Three Years1,2

  1998cited by this paper
• Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.

  1997cited by this paper
• Azathioprine and 6-Mercaptopurine in Crohn Disease

  1995cited by this paper
• Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  1995cited by this paper
• PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

  1995cited by this paper
• Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.

  1995cited by this paper
• Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.

  1995cited by this paper
• Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  1995cited by this paper
• Frequency of glucocorticoid resistance and dependency in Crohn's disease.

  1994cited by this paper
• Therapy of rheumatoid arthritis with mycophenolate mofetil.

  1993cited by this paper
• Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

  1993cited by this paper
• Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease.

  1993cited by this paper
• 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.

  1989cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

  1980cited by this paper

• Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn’s Disease

  2024cites this paper
• Management of Perianal Fistulizing Crohn's Disease.

  2023cites this paper
• Long-term Outcomes of Perianal Fistulas in Pediatric Crohn’s Disease

  2023cites this paper
• Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.

  2021cites this paper
• Perianal Crohn’s Disease

  2019cites this paper
• Biomarkers in Inflammatory Bowel Diseases

  2019cites this paper
• Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

  2018cites this paper
• Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

  2017cites this paper
• Immunosuppression following liver transplantation and the course of inflammatory bowel disease – a case control study

  2017cites this paper
• Perianal Crohn’s disease: A review

  2015cites this paper
• Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.

  2015cites this paper
• A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

  2014cites this paper
• Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.

  2014cites this paper
• Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.

  2014cites this paper
• What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

  2014cites this paper
• Drug-Induced Inflammatory Bowel Disease and IBD-Like Conditions

  2013cites this paper
• Managing Perianal Crohn’s Disease

  2012cites this paper
• Understanding the use of immunosuppressive agents in the clinical management of IBD.

  2011cites this paper
• Hyperuricemia in non‐alcoholic fatty liver disease

  2011cites this paper
• Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases

  2011cites this paper
• Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.

  2011cites this paper
• Perianal Crohn's disease: is there something new?

  2011cites this paper
• Understanding the use of immunosuppressive agents in the clinical management of IBD.

  2011cites this paper
• Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis.

  2010cites this paper
• Emerging treatments for complex perianal fistula in Crohn's disease.

  2009cites this paper
• Inflammation and its echo in atherosclerosis

  2009cites this paper
• Use of mycophenolate mofetil in inflammatory bowel disease.

  2009influential citation
• S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn”

  2008cites this paper
• [Crohn's disease].

  2008cites this paper
• Drug Safety in Crohn’s Disease Therapy

  2008cites this paper
• Maintenance of Medically Induced Remission of Crohn’s Disease

  2008cites this paper
• Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease.

  2008cites this paper
• Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease

  2008cites this paper
• Enterovesical Fistulas Secondary to Crohn's Disease: Medical versus Surgical Therapies

  2007cites this paper
• Current approach to gastrointestinal fistulae

  2007cites this paper
• Mycophenolate mofetil therapy for refractory inflammatory bowel disease

  2007cites this paper
• Enterovesical fistulas secondary to Crohn's disease:medical versus surgical therapies.

  2007cites this paper
• Crohn’s disease or abdominal tuberculosis?

  2007cites this paper
• Recent advances in the medical therapy of Crohn's disease in childhood

  2007cites this paper
• Biological Approach in the Treatment of Crohn’s Disease

  2006cites this paper
• Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road.

  2006cites this paper
• Basic immunosuppressive drugs outside solid organ transplantation

  2006cites this paper
• Review article: medical therapy for fistulizing Crohn's disease

  2006cites this paper
• Medical Therapy of Fistulizing Crohn’s Disease

  2006cites this paper
• Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

  2005cites this paper
• Perianal Crohn's disease

  2004cites this paper
• Index

  2004cites this paper